Altered mRNA expression of sialyltransferase in squamous cell carcinomas of the cervix

P H Wang1, Y F Li, C M Juang

  • 1Department of Obstetrics and Gynecology, Veterans General Hospital-Taipei, Taipei, Taiwan. phwang@vghtpe.gov.tw

Gynecologic Oncology
|October 5, 2001
PubMed
Abstract

Insights

Sialylation changes in cervical cancer were studied. Enhanced ST6Gal I mRNA and decreased ST3Gal I, III, IV mRNA expression were observed in squamous cell carcinoma, potentially aiding prognosis.

Area of Science:

  • Biochemistry
  • Oncology
  • Molecular Biology

Background:

  • Sialylation is implicated in various cancers.
  • Sialylation in cervical carcinoma remains unevaluated.
  • Sialyltransferases (STs) regulate sialylation.

Purpose of the Study:

  • To investigate messenger ribonucleic acid (mRNA) expression of four sialyltransferases (ST3Gal I, ST3Gal III, ST3Gal IV, and ST6Gal I) in normal cervix and FIGO stage IB1 squamous cell carcinoma.
  • To assess the role of sialylation in cervical cancer establishment.

Main Methods:

  • Semiquantitative reverse transcription-polymerase chain reaction (RT-PCR) was used.
  • mRNA expression of STs was analyzed in 30 cervical cancer tissues and 30 normal cervix tissues.

Main Results:

  • ST6Gal I mRNA expression was significantly increased in cervical squamous cell carcinoma.
  • mRNA expression of ST3Gal I, ST3Gal III, and ST3Gal IV was significantly decreased.
  • Elevated ST6Gal I expression correlated with increased invasiveness and poor differentiation.

Conclusions:

  • A combination of increased ST6Gal I and decreased ST3Gal I, III, IV mRNA expression may be significant in cervical cancer.
  • Further research is needed to determine if RT-PCR detection of these enzymes can aid in prognostic assessment.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...